NO920614L - Forbindelse med antitumorvirkning og fremstilling derav - Google Patents

Forbindelse med antitumorvirkning og fremstilling derav

Info

Publication number
NO920614L
NO920614L NO92920614A NO920614A NO920614L NO 920614 L NO920614 L NO 920614L NO 92920614 A NO92920614 A NO 92920614A NO 920614 A NO920614 A NO 920614A NO 920614 L NO920614 L NO 920614L
Authority
NO
Norway
Prior art keywords
antitum
relationship
preparation
effects
novel
Prior art date
Application number
NO92920614A
Other languages
English (en)
Other versions
NO300812B1 (no
NO920614D0 (no
Inventor
Katsuhisa Kojiri
Hiroyuki Suda
Akira Okura
Kenji Kawamura
Masanori Okanishi
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of NO920614D0 publication Critical patent/NO920614D0/no
Publication of NO920614L publication Critical patent/NO920614L/no
Priority to SE9301384A priority Critical patent/SE507907C2/sv
Publication of NO300812B1 publication Critical patent/NO300812B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/625—Streptoverticillium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/908—Streptovirticillium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO920614A 1989-03-23 1992-02-17 Fremgangsmåte for fremstilling av antitumorsubstans BE-13793C, samt biologisk ren kultur istand til å frembringe denne NO300812B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE9301384A SE507907C2 (sv) 1992-02-17 1993-04-26 Anläggning för kalkning av vattendrag

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7114989 1989-03-23
PCT/JP1990/000812 WO1991019716A1 (en) 1989-03-23 1990-06-20 Antitumor substance be-13793c

Publications (3)

Publication Number Publication Date
NO920614D0 NO920614D0 (no) 1992-02-17
NO920614L true NO920614L (no) 1992-03-24
NO300812B1 NO300812B1 (no) 1997-07-28

Family

ID=13452261

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920614A NO300812B1 (no) 1989-03-23 1992-02-17 Fremgangsmåte for fremstilling av antitumorsubstans BE-13793C, samt biologisk ren kultur istand til å frembringe denne

Country Status (13)

Country Link
US (2) US5106864A (no)
EP (1) EP0388956B1 (no)
JP (1) JP3010675B2 (no)
KR (1) KR0163202B1 (no)
AT (1) ATE110727T1 (no)
AU (1) AU634247B2 (no)
CA (1) CA2012955C (no)
DE (1) DE69011913T2 (no)
DK (1) DK0388956T3 (no)
ES (1) ES2063186T3 (no)
HU (1) HU210868A9 (no)
NO (1) NO300812B1 (no)
WO (1) WO1991019716A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0528030B1 (en) * 1990-05-11 1997-09-17 Banyu Pharmaceutical Co., Ltd. Antitumor be-13793c derivative
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5668271A (en) * 1991-11-29 1997-09-16 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
EP0630242B1 (en) * 1992-03-20 1999-01-20 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
WO1995034663A1 (fr) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene codant la glycosyl-transferase et utilisation de ce gene
US5808060A (en) * 1995-12-11 1998-09-15 Cephalon, Inc. Fused isoindolones
WO1997029205A1 (en) * 1996-02-07 1997-08-14 Banyu Pharmaceutical Co., Ltd. Effective production method of be-13793c
GB9811624D0 (en) * 1998-05-29 1998-07-29 Merck Sharp & Dohme Therapeutic use
WO2004083228A1 (ja) 1999-09-10 2004-09-30 Katsuhisa Kojiri インドロピロロカルバゾール誘導体及び抗腫瘍剤
FR2845996A1 (fr) * 2002-10-16 2004-04-23 Servier Lab Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE102006038635B4 (de) * 2006-08-19 2010-04-15 Josip Marinic Magnettonabnehmer für ein Saiteninstrument
JP7019601B2 (ja) 2016-07-12 2022-02-15 カリフォルニア インスティチュート オブ テクノロジー 高密度細胞増殖と代謝産物交換のための基材

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0826037B2 (ja) * 1987-01-22 1996-03-13 協和醗酵工業株式会社 生理活性物質ｋ−２５２の誘導体
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
CA2012955A1 (en) 1990-09-23
WO1991019716A1 (en) 1991-12-26
EP0388956A3 (en) 1991-10-02
EP0388956B1 (en) 1994-08-31
NO300812B1 (no) 1997-07-28
HU210868A9 (en) 1995-08-28
KR920703597A (ko) 1992-12-18
ATE110727T1 (de) 1994-09-15
DE69011913D1 (de) 1994-10-06
NO920614D0 (no) 1992-02-17
ES2063186T3 (es) 1995-01-01
AU634247B2 (en) 1993-02-18
DE69011913T2 (de) 1995-02-09
JPH0320277A (ja) 1991-01-29
CA2012955C (en) 2001-08-21
JP3010675B2 (ja) 2000-02-21
DK0388956T3 (da) 1994-11-14
US5290698A (en) 1994-03-01
US5106864A (en) 1992-04-21
AU5835190A (en) 1992-01-07
EP0388956A2 (en) 1990-09-26
KR0163202B1 (ko) 1998-12-01

Similar Documents

Publication Publication Date Title
NO920614L (no) Forbindelse med antitumorvirkning og fremstilling derav
PL292101A1 (en) Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine
YU69289A (en) Substituted flavonoidic compounds, their salts and process for producing thereof
HUT53368A (en) Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them
AU7886087A (en) Imide derivatives ,and their production and use
SE9003476D0 (sv) Novel isoindole derivatives and salts thereof, process for producing the same and antitumor agent comprising the same
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
EP0314098A3 (en) Imide derivatives, their production and use
FI101227B1 (fi) Menetelmä farmaseuttisesti aktiivisten 4-desoksi-4-epipodofyllotoksiinijohdannaisten valmistamiseksi
DK196688D0 (da) Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
ES2033279T3 (es) Procedimiento para preparar un compuesto a base de quinolina.
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
CS274700B2 (en) Method of bu-3608 antibiotics' complex n-alkyl derivatives production
YU46708B (sh) Postupak za dobijanje antibakterijskih derivata 9-dezoksi-9a-alil i propagril-9a-aza-9ahomoeritromicina
PT88568A (pt) Process for the preparation of saccharides derivatives
ES2044900T3 (es) Un proceso para la preparacion de un derivado de antraciclina.
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
NO923983D0 (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse
HUT60509A (en) Process for producing monomer and 125 i-marked derivatives of t-butyloxycarbonyl-l-tyrosylpeptidoglycan
DE3880304T2 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
HU912216D0 (en) Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them
GR3004095T3 (no)
EP0381138A3 (en) Antitumor substance be-12406